WAY-362450 100mg 100mg | Purity Not Available
Adooq Bioscience
WAY-362450 is a highly potent, selective, and orally bioavailable farnesoid X receptor (FXR) agonist (EC50: 4 nM, eff=149%).
More Information Supplier PageSearch Results
WAY-362450 10mg 10mg | Purity Not Available
Adooq Bioscience
WAY-362450 is a highly potent, selective, and orally bioavailable farnesoid X receptor (FXR) agonist (EC50: 4 nM, eff=149%).
More Information Supplier PageRibitol 200mg 200mg | Purity Not Available
Adooq Bioscience
Ribitol is a crystalline pentose alcohol formed by the reduction of ribose.
More Information Supplier PageRibitol (Adonitol) 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
Ribitol is a crystalline pentose alcohol formed by the reduction of ribose.
More Information Supplier PageClinofibrate 50mg 50mg | Purity Not Available
Adooq Bioscience
Clinofibrate is a lipid clearing agent that appears to modify lipid metabolism, diminishing the steroid induced accumulation of lipids within osteocytes. It also can effectively reduce the plasma fibrinogen level.
More Information Supplier PageClinofibrate 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
Clinofibrate is a lipid clearing agent that appears to modify lipid metabolism, diminishing the steroid induced accumulation of lipids within osteocytes. It also can effectively reduce the plasma fibrinogen level.
More Information Supplier PageWYE-687 10mg 10mg | Purity Not Available
Adooq Bioscience
WYE-687 is a novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin(mTOR).
More Information Supplier PageWYE-687 100mg 100mg | Purity Not Available
Adooq Bioscience
WYE-687 is a novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin(mTOR).
More Information Supplier PageSNX-2112 100mg 100mg | Purity Not Available
Adooq Bioscience
SNX-2112 is a heat shock protein 90 (Hsp90) inhibitor with anticancer properties currently in clinical trials. SNX-2112 induced autophagy in a time- and dose-dependent manner via Akt/mTOR/p70S6K inhibition. SNX-2112 induces significant apoptosis and autophagy in human melanoma A-375 cells, and may be an effective targeted therapy agent
More Information Supplier PageSNX-2112 10mg 10mg | Purity Not Available
Adooq Bioscience
SNX-2112 is a heat shock protein 90 (Hsp90) inhibitor with anticancer properties currently in clinical trials. SNX-2112 induced autophagy in a time- and dose-dependent manner via Akt/mTOR/p70S6K inhibition. SNX-2112 induces significant apoptosis and autophagy in human melanoma A-375 cells, and may be an effective targeted therapy agent
More Information Supplier Page